Interestingly, in an established multiple myeloma (MM) mouse model, intraperitoneal injection of 1.25 μg/g GW4869 for 2 weeks suppressed MM tumor growth, though no association with nSMase expression and sensitivity to GW4869 was observed. Here, SMPD2 is linked to Miyoshi myopathy.